Cargando…

Dealing with Macrophage Plasticity to Address Therapeutic Challenges in Head and Neck Cancers

The head and neck tumor microenvironment (TME) is highly infiltrated with macrophages. More specifically, tumor-associated macrophages (TAM/M2-like) are one of the most critical components associated with poor overall survival in head and neck cancers (HNC). Two extreme states of macrophage phenotyp...

Descripción completa

Detalles Bibliográficos
Autores principales: Furgiuele, Sonia, Descamps, Géraldine, Cascarano, Lorena, Boucq, Ambre, Dubois, Christine, Journe, Fabrice, Saussez, Sven
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9224268/
https://www.ncbi.nlm.nih.gov/pubmed/35742830
http://dx.doi.org/10.3390/ijms23126385
_version_ 1784733323612913664
author Furgiuele, Sonia
Descamps, Géraldine
Cascarano, Lorena
Boucq, Ambre
Dubois, Christine
Journe, Fabrice
Saussez, Sven
author_facet Furgiuele, Sonia
Descamps, Géraldine
Cascarano, Lorena
Boucq, Ambre
Dubois, Christine
Journe, Fabrice
Saussez, Sven
author_sort Furgiuele, Sonia
collection PubMed
description The head and neck tumor microenvironment (TME) is highly infiltrated with macrophages. More specifically, tumor-associated macrophages (TAM/M2-like) are one of the most critical components associated with poor overall survival in head and neck cancers (HNC). Two extreme states of macrophage phenotypes are described as conducting pro-inflammatory/anti-tumoral (M1) or anti-inflammatory/pro-tumoral (M2) activities. Moreover, specific metabolic pathways as well as oxidative stress responses are tightly associated with their phenotypes and functions. Hence, due to their plasticity, targeting M2 macrophages to repolarize in the M1 phenotype would be a promising cancer treatment. In this context, we evaluated macrophage infiltration in 60 HNC patients and demonstrated the high infiltration of CD68+ cells that were mainly related to CD163+ M2 macrophages. We then optimized a polarization protocol from THP1 monocytes, validated by specific gene and protein expression levels. In addition, specific actors of glutamine pathway and oxidative stress were quantified to indicate the use of glutaminolysis by M2 and the production of reactive oxygen species by M1. Finally, we evaluated and confirmed the plasticity of our model using M1 activators to repolarize M2 in M1. Overall, our study provides a complete reversible polarization protocol allowing us to further evaluate various reprogramming effectors targeting glutaminolysis and/or oxidative stress in macrophages.
format Online
Article
Text
id pubmed-9224268
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-92242682022-06-24 Dealing with Macrophage Plasticity to Address Therapeutic Challenges in Head and Neck Cancers Furgiuele, Sonia Descamps, Géraldine Cascarano, Lorena Boucq, Ambre Dubois, Christine Journe, Fabrice Saussez, Sven Int J Mol Sci Article The head and neck tumor microenvironment (TME) is highly infiltrated with macrophages. More specifically, tumor-associated macrophages (TAM/M2-like) are one of the most critical components associated with poor overall survival in head and neck cancers (HNC). Two extreme states of macrophage phenotypes are described as conducting pro-inflammatory/anti-tumoral (M1) or anti-inflammatory/pro-tumoral (M2) activities. Moreover, specific metabolic pathways as well as oxidative stress responses are tightly associated with their phenotypes and functions. Hence, due to their plasticity, targeting M2 macrophages to repolarize in the M1 phenotype would be a promising cancer treatment. In this context, we evaluated macrophage infiltration in 60 HNC patients and demonstrated the high infiltration of CD68+ cells that were mainly related to CD163+ M2 macrophages. We then optimized a polarization protocol from THP1 monocytes, validated by specific gene and protein expression levels. In addition, specific actors of glutamine pathway and oxidative stress were quantified to indicate the use of glutaminolysis by M2 and the production of reactive oxygen species by M1. Finally, we evaluated and confirmed the plasticity of our model using M1 activators to repolarize M2 in M1. Overall, our study provides a complete reversible polarization protocol allowing us to further evaluate various reprogramming effectors targeting glutaminolysis and/or oxidative stress in macrophages. MDPI 2022-06-07 /pmc/articles/PMC9224268/ /pubmed/35742830 http://dx.doi.org/10.3390/ijms23126385 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Furgiuele, Sonia
Descamps, Géraldine
Cascarano, Lorena
Boucq, Ambre
Dubois, Christine
Journe, Fabrice
Saussez, Sven
Dealing with Macrophage Plasticity to Address Therapeutic Challenges in Head and Neck Cancers
title Dealing with Macrophage Plasticity to Address Therapeutic Challenges in Head and Neck Cancers
title_full Dealing with Macrophage Plasticity to Address Therapeutic Challenges in Head and Neck Cancers
title_fullStr Dealing with Macrophage Plasticity to Address Therapeutic Challenges in Head and Neck Cancers
title_full_unstemmed Dealing with Macrophage Plasticity to Address Therapeutic Challenges in Head and Neck Cancers
title_short Dealing with Macrophage Plasticity to Address Therapeutic Challenges in Head and Neck Cancers
title_sort dealing with macrophage plasticity to address therapeutic challenges in head and neck cancers
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9224268/
https://www.ncbi.nlm.nih.gov/pubmed/35742830
http://dx.doi.org/10.3390/ijms23126385
work_keys_str_mv AT furgiuelesonia dealingwithmacrophageplasticitytoaddresstherapeuticchallengesinheadandneckcancers
AT descampsgeraldine dealingwithmacrophageplasticitytoaddresstherapeuticchallengesinheadandneckcancers
AT cascaranolorena dealingwithmacrophageplasticitytoaddresstherapeuticchallengesinheadandneckcancers
AT boucqambre dealingwithmacrophageplasticitytoaddresstherapeuticchallengesinheadandneckcancers
AT duboischristine dealingwithmacrophageplasticitytoaddresstherapeuticchallengesinheadandneckcancers
AT journefabrice dealingwithmacrophageplasticitytoaddresstherapeuticchallengesinheadandneckcancers
AT saussezsven dealingwithmacrophageplasticitytoaddresstherapeuticchallengesinheadandneckcancers